Wolff Wiese Magana’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.6K Buy
321
+1
+0.3% +$207 0.03% 212
2026
Q1
$71.9K Hold
320
0.04% 181
2025
Q4
$77K Buy
320
+1
+0.3% +$256 0.04% 168
2025
Q3
$87.3K Buy
319
+1
+0.3% +$273 0.05% 166
2025
Q2
$82.1K Buy
318
+1
+0.3% +$239 0.05% 163
2025
Q1
$71.1K Hold
317
0.05% 163
2024
Q4
$72.4K Buy
317
+1
+0.3% +$241 0.05% 162
2024
Q3
$77.2K Buy
316
+1
+0.3% +$223 0.05% 155
2024
Q2
$60.4K Buy
315
+5
+2% +$1.01K 0.05% 150
2024
Q1
$61.3K Buy
310
+1
+0.3% +$183 0.05% 133
2023
Q4
$53.1K Sell
309
-4
-1% -$615 0.05% 135
2023
Q3
$46.3K Buy
313
+6
+2% +$1.08K 0.04% 189
2023
Q2
$67.1K Buy
307
+1
+0.3% +$223 0.05% 165
2023
Q1
$67.1K Sell
306
-1
-0.3% -$217 0.05% 160
2022
Q4
$63.8K Hold
307
0.05% 162
2022
Q3
$67K Buy
307
+2
+0.7% +$455 0.05% 199
2022
Q2
$64K Buy
305
+1
+0.3% +$213 0.05% 219
2022
Q1
$74K Buy
304
+1
+0.3% +$242 0.05% 218
2021
Q4
$79K Hold
303
0.05% 225
2021
Q3
$80K Buy
303
+1
+0.3% +$273 0.06% 223
2021
Q2
$75K Hold
302
0.05% 227
2021
Q1
$59K Buy
302
+1
+0.3% +$201 0.05% 251
2020
Q4
$64K Buy
+301
New +$60K 0.05% 227

Other funds holding RMD

Wolff Wiese Magana's RMD Position: Q2 2026 in Review

Wolff Wiese Magana increased its ResMed (RMD) stake by 0.31% in Q2 2026, buying an estimated $207 and bringing the position to 321 shares worth $62.6K. The position accounts for 0.03% of the portfolio, ranked #212.

Wolff Wiese Magana first reported a position in RMD in Q4 2020 and has held it in 23 quarters since. The position peaked at $87.3K in Q3 2025. 149 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Wolff Wiese Magana held 321 shares of ResMed worth $62.6K as of Q2 2026.
  • Wolff Wiese Magana bought 1 ResMed share in Q2 2026, an estimated $207.
  • ResMed made up 0.03% of Wolff Wiese Magana's portfolio in Q2 2026, its #212 holding.
  • Wolff Wiese Magana first reported a position in ResMed in Q4 2020 and has held it in 23 quarters since.
  • Wolff Wiese Magana's ResMed position peaked at $87.3K in Q3 2025.
  • 149 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.